Wall Street analysts have issued positive earnings forecasts and a buy rating for Thermo Fisher Scientific Inc. following a recent earnings beat.
These estimates provide a benchmark for investors to gauge the company's growth trajectory within the competitive life-sciences sector. The outlook reflects confidence in the company's ability to scale its operations from its headquarters in Waltham, Massachusetts.
For the second quarter of fiscal year 2026, analysts project earnings per share of $5.71 [1]. This figure accompanies a projected revenue of $11.68 billion for the same period [1]. These forecasts suggest a steady financial performance as the company continues to navigate the global healthcare market.
Market analysts have maintained a bullish stance on the stock, which trades on the New York Stock Exchange under the ticker TMO. Barclays analyst Matt Miksic said the price target for the shares is $96.00 [2]. This target represents a significant increase over the share price, which recently closed at $59.95 [2].
Thermo Fisher Scientific provides a wide array of instruments and reagents used in medical research and diagnostics. The current analyst ratings serve as a guide for investors looking to capitalize on the company's recent momentum, a trend bolstered by the company's ability to exceed previous financial expectations.
The life-sciences industry remains sensitive to shifts in research funding and government health spending. However, the current projections from analysts indicate that Thermo Fisher is well-positioned to maintain its market share through the remainder of the fiscal year.
“Analysts project earnings per share of $5.71 for Q2 FY2026.”
The gap between the current closing price of $59.95 and the $96 price target suggests that analysts believe the market is currently undervaluing Thermo Fisher Scientific. By forecasting strong Q2 revenue and earnings, experts are signaling that the company's recent earnings beat was not an isolated incident but a sign of sustainable growth in the life-sciences sector.
